Communiqués

13/04/22 Form 8.3 - Lupus alpha Asset Management AG: Sensyne Health PLC EQ
18/01/22 Invesco Ltd. Form 8.3 Sensyne Health Plc AQ
17/01/22 Form 8.3 - Octopus Investments - Sensyne Health plc AQ
03/11/21 Invesco Ltd.: Form 8 (OPD) - Sensyne Health PLC AQ
02/11/21 Form 8.3 - Octopus Investments - Sensyne Health plc AQ
09/09/21 Sensyne Health : launches SENSIGHT – a real world patient data analytics platform for the life science and healthcare industries BU
19/08/21 Sensyne Health : and Sentara Healthcare Form New Partnership for Ethical Data Sharing and Design of New Clinical Algorithms BU
02/08/21 Sensyne Health : grows medical research dataset to 60 million patients BU
22/07/21 Sensyne Health : Appointment of Chief Scientific Officer AQ
24/05/21 Sensyne Health : Signs Strategic Research Agreement with the Colorado Center for Personalized Medicine BU
21/05/21 Sensyne Health : and Phesi Enter Joint Commercial Development Collaboration with a Leading Pharmaceutical Company BU
21/05/21 Sensyne Health : Signs First US Strategic Research Agreement with St. Luke’s University Health Network BU
15/12/20 Sensyne Health : Launches First Digital Health Product in the U.S. BU
13/11/20 Sensyne Health : appoints President, North America, to lead US expansion AQ
30/09/20 Sensyne Health : Full Year Results AQ
19/05/20 Sensyne Health : Clinical AI Leader Sensyne Health Launches CVm-Health™ ‘Good Neighbor’ App in the United States With Support From Microsoft and Cognizant BU
02/03/20 Sensyne Health : Interim Chief Financial Officer appointment PU
28/02/20 Sensyne Health : HSJ Partnership Award for GDm-Health PU
16/12/19 Sensyne Health : Update Following General Election PU
Aucun résultat pour cette recherche